Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleonore Real

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
ACS Chemical Biology|December 14, 2017
Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 StrainsMattia Mori, Lesia Kovalenko, Savina Malancona, et al.
ACS Infectious Diseases|February 12, 2020
(Thia)calixarenephosphonic Acids as Potent Inhibitors of the Nucleic Acid Chaperone Activity of the HIV-1 Nucleocapsid Protein with a New Binding Mode and Multitarget Antiviral ActivityNicolas Humbert, Lesia Kovalenko, Francesco Saladini, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid ProteinSavina Malancona, Mattia Mori, Paola Fezzardi, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
ACS Chemical Biology|December 14, 2017
Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 StrainsMattia Mori, Lesia Kovalenko, Savina Malancona, et al.
ACS Infectious Diseases|February 12, 2020
(Thia)calixarenephosphonic Acids as Potent Inhibitors of the Nucleic Acid Chaperone Activity of the HIV-1 Nucleocapsid Protein with a New Binding Mode and Multitarget Antiviral ActivityNicolas Humbert, Lesia Kovalenko, Francesco Saladini, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid ProteinSavina Malancona, Mattia Mori, Paola Fezzardi, et al.
Pageof 2